Abstract
Purpose
This study aimed to investigate the clinical features and risk factors for poor visual outcomes in patients with endogenous Klebsiella pneumoniae endophthalmitis (EKE).
Methods
This retrospective interventional case series reviewed the medical records of 17 patients (21 eyes) with EKE from January 2007 to December 2019. Clinical findings, treatments, visual outcomes, and potential prognostic factors were evaluated.
Results
The mean age of the patients was 55.9 years and 13 patients (76.5%) were males. Diabetes (23.5%) was the most commonly associated systemic disease and liver abscess (70.6%) was the major infection source. Poor initial visual acuity worse than counting fingers was significantly associated with poor final visual outcome (p = 0.003). In this study, adjunctive intravitreal dexamethasone injection and primary vitrectomy were not associated with final visual outcome. Secondary enucleation/evisceration was performed in 14.3%.
Conclusions
EKE usually has a poor visual prognosis, and early diagnosis with fair initial visual acuity would be crucial in saving vision.
Similar content being viewed by others
References
Shrader SK, Band JD, Lauter CB, Murphy P (1990) The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 162:115–120. https://doi.org/10.1093/infdis/162.1.115
Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS (1994) Endogenous bacterial endophthalmitis. report of a ten-year retrospective study. Ophthalmology 101:832–838
Jackson TL, Eykyn SJ, Graham EM, Stanford MR (2003) Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 48:403–423. https://doi.org/10.1016/S0039-6257(03)00054-7
Connell PP, O’Neill EC, Fabinyi D et al (2011) Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond) 25:66–72. https://doi.org/10.1038/eye.2010.145
Schiedler V, Scott IU, Flynn HW, Davis JL, Benz MS, Miller D (2004) Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 137:725–731. https://doi.org/10.1016/j.ajo.2003.11.013
Cho H, Shin YU, Siegel NH et al (2018) Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm 26:496–503. https://doi.org/10.1080/09273948.2016.1195000
Kashani AH, Eliott D (2013) The emergence of klebsiella pneumoniae endogenous endophthalmitis in the USA: basic and clinical advances. J Ophthalmic Inflamm Infect 3:28. https://doi.org/10.1186/1869-5760-3-28
Sridhar J, Flynn HW Jr, Kuriyan AE, Dubovy S, Miller D (2014) Endophthalmitis caused by klebsiella species. Retina 34:1875–1881. https://doi.org/10.1097/iae.0000000000000162
Odouard C, Ong D, Shah PR et al (2017) Rising trends of endogenous klebsiella pneumoniae endophthalmitis in Australia. Clin Exp Ophthalmol 45:135–142. https://doi.org/10.1111/ceo.12827
The IONDT Research Group (1998) The ischemic optic neuropathy decompression trial (IONDT): design and methods. Control Clin Trials 19:276–296. https://doi.org/10.1016/s0197-2456(98)00003-8
Bagley ST (1985) Habitat association of klebsiella species. Infect Control 6:52–58. https://doi.org/10.1017/s0195941700062603
Fazili T, Sharngoe C, Endy T, Kiska D, Javaid W, Polhemus M (2016) Klebsiella pneumoniae liver abscess: an emerging disease. Am J Med Sci 351:297–304. https://doi.org/10.1016/j.amjms.2015.12.018
Lin JC, Siu LK, Fung CP et al (2006) Impaired phagocytosis of capsular serotypes K1 or K2 klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab 91:3084–3087. https://doi.org/10.1210/jc.2005-2749
Chee SP, Jap A (2001) Endogenous endophthalmitis. Curr Opin Ophthalmol 12:464–470. https://doi.org/10.1097/00055735-200112000-00012
Li YH, Chen YH, Chen KJ et al (2018) Infectious sources, prognostic factors, and visual outcomes of endogenous klebsiella pneumoniae endophthalmitis. Ophthalmol Retina 2:771–778. https://doi.org/10.1016/j.oret.2017.11.013
Kim TK, Lee JH, Baek J, Paik JS, Park J, Lee MY (2017) Two cases of endogenous endophthalmitis that progressed to globe rupture. Korean J Ophthalmol 31:279–281. https://doi.org/10.3341/kjo.2017.0002
Wood EH, Powers MA, Moshfeghi DM (2017) Spontaneous globe rupture due to rapidly evolving endogenous hypermucoid klebsiella pneumoniae endophthalmitis. Ophthalmic Surg Lasers Imagin Retina 48:600–601. https://doi.org/10.3928/23258160-20170630-14
Ang M, Jap A, Chee SP (2011) Prognostic factors and outcomes in endogenous klebsiella pneumoniae endophthalmitis. Am J Ophthalmol 151:338-344.e332. https://doi.org/10.1016/j.ajo.2010.08.036
Sheu SJ, Kung YH, Wu TT, Chang FP, Horng YH (2011) Risk factors for endogenous endophthalmitis secondary to klebsiella pneumoniae liver abscess: 20-year experience in Southern Taiwan. Retina 31:2026–2031. https://doi.org/10.1097/IAE.0b013e31820d3f9e
Chen YH, Li YH, Lin YJ et al (2019) Prognostic factors and visual outcomes of pyogenic liver abscess-related endogenous klebsiella pneumoniae endophthalmitis: a 20-year retrospective review. Sci Rep 9:1071. https://doi.org/10.1038/s41598-018-37643-y
Chen KJ, Chen YP, Chao AN et al (2017) Prevention of evisceration or enucleation in endogenous bacterial panophthalmitis with no light perception and scleral abscess. PLoS ONE 12:e0169603. https://doi.org/10.1371/journal.pone.0169603
Yang CS, Tsai HY, Sung CS, Lin KH, Lee FL, Hsu WM (2007) Endogenous klebsiella endophthalmitis associated with pyogenic liver abscess. Ophthalmology 114:876–880. https://doi.org/10.1016/j.ophtha.2006.12.035
Park SS, Samiy N, Ruoff K, D’Amico DJ, Baker AS (1995) Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 113:1324–1329. https://doi.org/10.1001/archopht.1995.01100100112040
Meredith TA, Aguilar HE, Drews C et al (1996) Intraocular dexamethasone produces a harmful effect on treatment of experimental staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc 94:241–257. https://doi.org/10.1016/s0002-9394(14)70164-3
Jett BD, Jensen HG, Atkuri RV, Gilmore MS (1995) Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing enterococcus faecalis strains. Invest Ophthalmol Vis Sci 36:9–15
Jackson TL, Paraskevopoulos T, Georgalas I (2014) Systematic review of 342 cases of endogenous bacterial endophthalmitis. Surv Ophthalmol 59:627–635. https://doi.org/10.1016/j.survophthal.2014.06.002
Chen SC, Lee YY, Chen YH, Lin HS, Wu TT, Sheu SJ (2017) Klebsiella pneumoniae infection leads to a poor visual outcome in endogenous endophthalmitis: a 12-year experience in Southern Taiwan. Ocul Immunol Inflamm 25:870–877. https://doi.org/10.1080/09273948.2016.1193616
Shields RA, Smith SJ, Pan CK, Do DV (2019) Endogenous klebsiella pneumoniae endophthalmitis in Northern California. Retina 39:614–620. https://doi.org/10.1097/iae.0000000000001994
Liu YL, Chen MS, Huang JS, Ho TC (2012) Oral levofloxacin brings better results in treating endogenous klebsiella pneumoniae endophthalmitis. J Ocul Pharmacol Ther 28:1–2. https://doi.org/10.1089/jop.2011.0182
Ko CS, Sung JY, Koo SH, Kwon GC, Shin SY, Park JW (2007) Prevalence of extended-spectrum beta-lactamases in escherichia coli and klebsiella pneumoniae from Daejeon. Korean J Lab Med 27:344–350. https://doi.org/10.3343/kjlm.2007.27.5.344
Yoo JS, Byeon J, Yang J, Yoo JI, Chung GT, Lee YS (2010) High prevalence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases in enterobacteriaceae isolated from long-term care facilities in Korea. Diagn Microbiol Infect Dis 67:261–265. https://doi.org/10.1016/j.diagmicrobio.2010.02.012
Palmer SM, Kang SL, Cappelletty DM, Rybak MJ (1995) Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and klebsiella pneumoniae in an in vitro infection model. Antimicrob Agent Chemother 39:1764–1771. https://doi.org/10.1128/aac.39.8.1764
Fekete T, Tumah H, Woodwell J, Satishchandran V, Truant A, Axelrod P (1996) Comparative susceptibilities of klebsieila species, enterobacter species, and pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospital. Am J Med 100:20S-25S. https://doi.org/10.1016/S0002-9343(96)00104-0
Lim SW, Sung Y, Kwon HJ, Song WK (2020) Endogenous endophthalmitis associated with liver abscess successfully treated with vitrectomy and intravitreal empirical antibiotics injections. Case Rep Ophthalmol Med 2020:8165216. https://doi.org/10.1155/2020/8165216
Lee S, Um T, Joe SG et al (2012) Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea. Retina 32:977–984. https://doi.org/10.1097/IAE.0b013e318228e312
Modjtahedi BS, Finn AP, Barb SM et al (2019) Characteristics and outcomes of endogenous endophthalmitis: eight-year experience at a tertiary care center. Ophthalmol Retina 3:61–72. https://doi.org/10.1016/j.oret.2018.08.009
Funding
This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) under 2019R1A2C2002393 (C.S.L.). The funding organization had no role in the design or conduct of this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Ethical approval
This study was approved by the institutional review board of Severance Hospital, Yonsei University College of Medicine (IRB No. 2021–2065-001), and patient informed consent was not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Presented in Part as an Oral Presentation at 15th International Ocular Inflammation Society Congress 2019, Kaohsiung, Taiwan.
Rights and permissions
About this article
Cite this article
Lee, J.H., Kim, H.S., Byeon, S.H. et al. Clinical characteristics of endogenous Klebsiella pneumoniae endophthalmitis: a 13-year experience. Int Ophthalmol 42, 2533–2539 (2022). https://doi.org/10.1007/s10792-022-02301-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02301-w